Krystal Biotech (KRYS) PT Raised to $395 at Evercore ISI
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Price: $336.80 -0.67%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Join SI Premium – FREE
Evercore ISI analyst Josh Schimmer raised the price target on Krystal Biotech (NASDAQ: KRYS) to $395.00 (from $300.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Krystal Biotech to join S&P MidCap 400, Tutor Perini and V2X to join S&P SmallCap 600
- Chocoladefabriken Lindt & Spruengli AG (LISN:SW) (LDSVF) PT Lowered to CHF112,000 at Kepler Cheuvreux
- Freedom Broker Upgrades Halliburton (HAL) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
